Extended Data Fig. 8: CD4+ T cell count and CD4/CD8 ratio during the study. | Nature Medicine

Extended Data Fig. 8: CD4+ T cell count and CD4/CD8 ratio during the study.

From: Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Extended Data Fig. 8: CD4+ T cell count and CD4/CD8 ratio during the study.

Tukey plots depicts the CD4+ T cell count (a) and CD4/CD8 ratio (b) in the four groups at baseline (day 0), the interventional period (day 10–30) and during follow-up (day 90–365). Lines indicates median, boxes represent interquartile ranges and whiskers drawn within the 1.5 IQR values. ART only n = 15, ART + 3BNC117 n = 15, ART + RMD n = 13, ART + 3BNC117 + RMD n = 16. ART, antiretroviral therapy; IQR, interquartile range; RMD, romidepsin.

Back to article page